. Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. Mov Disord. 2014 Sep;29(10):1273-80. Epub 2014 Jul 10 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. New Parkinson’s Treatments Given Green Light

Therapeutics

  1. Safinamide